Alternatives to Xaira Therapeutics

Iambic Therapeutics pairs Enchant v3 and NeuralPLexer AI drug discovery models with a weekly wet lab and a wholly owned clinical pipeline.

AI drug discovery from Isomorphic Labs: predictive and generative models that design molecules and forecast drug performance.

AI-native drug discovery company pairing 20+ petabytes of cellular data with human genetics to find causal disease targets

Dotmatics pairs an agentic scientific intelligence platform with Luma Agent for governed R&D data analysis.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and an autonomous robotic DMTA lab.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

A research-stage AI platform for discovering neurotherapeutics that act on neural circuits across multiple disorders.

Physics-based molecular simulation and AI for drug discovery and materials design.

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Owkin pairs K Pro, an autonomous AI scientist, with 25 million patients' data across 840 hospitals and wet lab validation for drug R&D

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

NovaFlow is an AI data analyst for biology labs that turns raw sequencing output into cited, publication-ready results.

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

AI drug discovery driven by a wet-and-dry lab-in-the-loop that runs millions of weekly cell experiments.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Proton powers AI-first medicinal chemistry and synthesis-aware molecule design for partnered drug discovery programs.

Nanograb designs peptide-LNP targeting systems with biophysics-informed AI so genetic medicines reach a chosen cell type instead of the

Infera compiles written lab protocols into validated, instrument-ready liquid-handler runs.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Cloud R&D platform combining ELN, LIMS, automation, and agent-driven Science Foundries for biotech.

AI protein engineering platform that designs optimized variant plates and learns from every wet-lab round.

Cellbyte gives pharma Pricing & Market Access teams source-linked HTA and pricing answers in minutes, not weeks.

Oncology real-world evidence built from point-of-care data, with AI-driven insights across a global database of six million+ patients.

Cellino's AI-guided optical bioprocessing platform brings patient-specific cell therapy manufacturing to the hospital.

Generative protein design that has produced antibodies, enzymes, and cytokines now in the clinic.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days